India, June 12 -- Elon Musk's spacecraft maker Space Exploration Technologies Corp. or SpaceX confirmed the pricing of its initial public offering or IPO of 555.56 million shares of its Class A common... Read More
India, June 12 -- Indian shares opened on a buoyant note on Friday after U.S. President Donald Trump cancelled a third consecutive day of strikes on Iran and claimed that a peace deal with Tehran is c... Read More
India, June 11 -- Treasure Global Inc. (TGL) shares declined 16.89 percent, losing $0.8899 to $4.30 on Thursday despite the company announcing that it had been awarded a $15 million contract by Creati... Read More
India, June 11 -- Today's top gainers were led by Australia-based Gelteq, which develops a novel ingestible gel-based drug delivery platform; Adial Pharmaceuticals, which announced the acquisition of ... Read More
India, June 11 -- Shares of Dana Incorporated (DAN) on Thursday slipped over 13% after the company announced an agreement to combine with Eaton Corporation plc's Mobility business in a transaction val... Read More
India, June 11 -- Enliven Therapeutics, Inc. (ELVN), reported on Thursday an updated positive result from the Phase 1 ENABLE trial of ELVN-001 in patients who were previously treated for Chronic Myelo... Read More
India, June 11 -- Shares of Navan, Inc. (NAVN) gained over 14% on Thursday morning after the company reported strong first-quarter results and raised its full-year guidance. The stock is currently tr... Read More
India, June 11 -- Cartesian Therapeutics, Inc. (RNAC) is entering a catalyst-rich period as it advances Descartes-08, its RNA-engineered CAR-T therapy designed for autoimmune diseases, toward late-sta... Read More
India, June 11 -- Atossa Therapeutics, Inc. (ATOS) has entered into a securities purchase agreement with institutional investors for a registered direct offering of up to $16.5 million in gross procee... Read More
India, June 11 -- Dr. Philip Werschler, dermatologist and clinical investigator for AbbVie Inc. (ABBV)'s investigational TrenibotulinumtoxinE program, that received a Complete Response Letter, or CRL,... Read More